Finance

Lists
GETI-B:STO
Getinge publ AB
SEK 277.80
-1.66%
(-4.70) 1D
11-р сарын 6, 17:29:46 (GMT+1)  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for GETI-B...
Open
SEK 278.90
High
SEK 280.00
Low
SEK 274.30
Mkt. cap
70.60 тэрбум
Avg. vol.
535.61 мян
Volume
522.26 мян
Dividend
1.71%
Quarterly dividend
SEK 1.19
Ex-dividend date
2026 оны 4-р сарын 22
P/E ratio
26.76
52-wk high
SEK 283.00
52-wk low
SEK 175.90
EPS
SEK 10.38
Shares outstanding
254.15 сая
No. of employees
12 мян
Open
SEK 278.90
High
SEK 280.00
Low
SEK 274.30
Mkt. cap
70.60 тэрбум
Avg. vol.
535.61 мян
Volume
522.26 мян
Dividend
1.71%
Quarterly dividend
SEK 1.19
Ex-dividend date
2026 оны 4-р сарын 22
P/E ratio
26.76
52-wk high
SEK 283.00
52-wk low
SEK 175.90
EPS
SEK 10.38
Shares outstanding
254.15 сая
No. of employees
12 мян
News stories
From web sources and news partners
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB
CEOMattias Perjos
Employees11.8 мян
Founded1904
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
2026 оны 9-р сар
Revenue
10.19 тэрбум
7.44 тэрбум
8.38 тэрбум
8.45 тэрбум
Cost of goods sold
5.38 тэрбум
3.84 тэрбум
3.96 тэрбум
4.38 тэрбум
Cost of revenue
5.38 тэрбум
3.84 тэрбум
3.96 тэрбум
4.38 тэрбум
Research and development expenses
484.00 сая
328.00 сая
358.00 сая
363.00 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.76 тэрбум
2.55 тэрбум
2.71 тэрбум
2.58 тэрбум
Operating expense
3.10 тэрбум
2.87 тэрбум
3.06 тэрбум
2.93 тэрбум
Total operating expenses
8.49 тэрбум
6.70 тэрбум
7.03 тэрбум
7.31 тэрбум
Operating income
1.70 тэрбум
738.00 сая
1.35 тэрбум
1.14 тэрбум
Other non operating income
-105.00 сая
-1.00 сая
-
-1.00 сая
EBT including unusual items
1.21 тэрбум
572.00 сая
1.15 тэрбум
973.00 сая
EBT excluding unusual items
1.26 тэрбум
602.00 сая
1.22 тэрбум
1.00 тэрбум
Income tax expense
338.00 сая
170.00 сая
312.00 сая
248.00 сая
Effective tax rate
28.03%
29.72%
27.11%
25.49%
Other operating expenses
-136.00 сая
-12.00 сая
-
-18.00 сая
Net income
868.00 сая
401.00 сая
841.00 сая
719.00 сая
Net profit margin
8.52%
5.39%
10.03%
8.51%
Earnings per share
4.45
1.80
3.59
3.10
Interest and investment income
73.00 сая
-
-
-
Interest expense
-103.00 сая
-135.00 сая
-133.00 сая
-134.00 сая
Net interest expenses
-30.00 сая
-135.00 сая
-133.00 сая
-134.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
1.97 тэрбум
1.01 тэрбум
1.63 тэрбум
1.44 тэрбум
Gain or loss from assets sale
40.00 сая
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google аппс